Neumora Therapeutics, Inc. (NMRA) — Defensive Interval Ratio
Neumora Therapeutics, Inc. (NMRA) has a Defensive Interval Ratio of 600 days as of September 2025. Defensive assets of $42.45 Million (cash $-, short-term investments $42.45 Million, receivables $-) cover 600 days of daily cash needs of $70.80K/day. Check NMRA goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Neumora Therapeutics, Inc. Defensive Interval Ratio (2020–2024)
This chart shows how Neumora Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 600 days, meaning defensive assets of $42.45 Million can fund 600 days of operations without new revenue. Also explore NMRA shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Neumora Therapeutics, Inc. (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for Neumora Therapeutics, Inc. from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Neumora Therapeutics, Inc. stock valuation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2020 days | $165.43 Million | $81.88K/day | $- | $165.43 Million | ▲ +845 days |
| 2023 | 1176 days | $80.88 Million | $68.80K/day | $- | $79.94 Million | ▼ -855 days |
| 2022 | 2031 days | $131.86 Million | $64.92K/day | $- | $130.94 Million | ▲ +2028 days |
| 2021 | 3 days | $200.00K | $63.78K/day | $- | $0.00 | ▼ -3 days |
| 2020 | 6 days | $148.00K | $25.67K/day | $- | $- | — |